Ironwood Pharmaceuticals | IRWD - Acreedores Comerciales

Precio De Mercado
4.18
Cambio Diario
-0.04 -0.95%
Mensual
14.52%
Anual
469.64%
Q2 Expectativa
4.13




Acreedores Comerciales Cambio Fecha
Acadia Pharmaceuticals USD 12.25M 1.34M 2026-03
Agios Pharmaceuticals USD 13.75M 4.61M 2026-03
Akebia Therapeutics USD 8.39M 12.8M 2026-03
Almirall EUR 258.05M 58.66M 2025-12
Alnylam Pharmaceuticals USD 126.63M 10.91M 2026-03
Amarin USD 48.15M 2.8M 2026-03
Ardelyx USD 28.2M 8.96M 2026-03
Astellas Pharma JPY 199.75B 17.8B 2026-03
AstraZeneca USD 22.51B 2.78B 2026-03
Charles River Laboratories USD 133.95M 14.85M 2026-03
Coherus Biosciences USD 9.91M 14.98M 2025-12
Emergent BioSolutions USD 112.2M 500K 2023-12
Esperion Therapeutics USD 68.41M 3.34M 2026-03
Halozyme Therapeutics USD 20.9M 5.54M 2025-12
Incyte USD 228.62M 1.41B 2026-03
Ironwood Pharmaceuticals USD 3.24M 339K 2026-03
Karyopharm Therapeutics USD 4M 1.39M 2025-12
Lexicon Pharmaceuticals USD 3M 87K 2026-03
MacroGenics USD 4.79M 1.15M 2025-12
Moderna USD 161M 156M 2026-03
Myriad Genetics USD 32.6M 2.6M 2026-03
Pacira USD 14.01M 1.14M 2026-03
PTC Therapeutics USD 25.48M 20M 2026-03
Puma Biotechnology USD 6.39M 962K 2025-09
Sarepta Therapeutics USD 70.38M 210.46M 2026-03
Takeda JPY 467.59B 28.61B 2025-12
Ultragenyx Pharmaceutical USD 42M 11M 2026-03
Vanda Pharmaceuticals USD 39.09M 33.28M 2024-12